(9926.HK) today announced that results from a Phase II clinical study evaluating its first-in-class PD-1/VEGF bispecific ...

A groundbreaking, first-of-its-kind advancement marks a new era in reverse shoulder arthroplasty, culminating in eight years ...

MNTN reported third-quarter 2026 adjusted earnings of $0.10 per share, missing the $0.25 consensus, and cut its full-year ...

Veracyte stock fell more than 50% after the Company reported on November 4, 2026 that Decipher Prostate volume fell short of ...

NEWPORT, R.I., Nov. 5, 2026 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (Nasdaq: PANL), a ...

"The Arc is a significant investment in Rice's future and in Houston's continued growth as a center for innovation," said ...

This project represents the second inpatient rehabilitation hospital partnership between Tampa General Hospital and Lifepoint ...

WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- A new study released today by the U.S. Chamber of Commerce Institute for Legal ...

Ameren Transmission third quarter 2026 earnings were $110 million, compared to third quarter 2025 GAAP and adjusted earnings ...

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, announced that the New Drug Application (NDA) ...

Major Investors Are Skeptical Anthropic IPO Can Achieve $1.5 Trillion Valuation The artificial intelligence giant could need to set a significantly lower-than-expected valuation, investors say. Japan ...

How do Americans feel about the midterm results? It depends on how much money they make.